All Posts:mRNA vaccine

• New Study Finds Personalized mRNA Vaccine Given with Immunotherapy Reduces Recurrence in High-Risk Melanoma Patients

  A new study conducted by an international team of researchers, including clinical investigators at Georgetown Lombardi and John Theurer Cancer Center, demonstrates that a personalized cancer mRNA vaccine combined with immunotherapy reduces recurrence and improves survival for people with advanced melanoma.

  Category: News Release Tags: cancer, cancer research, clinical trials, immunotherapy, melanoma, mRNA vaccine, research